OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Antonio Bruno, Ettore Dolcetti, Francesca Romana Rizzo, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria Saldana, Johannes Finnstein, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 284-297
Open Access | Times Cited: 249

Association between vascular endothelial growth factor-mediated blood–brain barrier dysfunction and stress-induced depression
Hitomi Matsuno, Shoko Tsuchimine, Kazunori Ohashi, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3822-3832
Closed Access | Times Cited: 93

Antidepressant psychopharmacology: is inflammation a future target?
Francesco Benedetti, Raffaella Zanardi, Mario Gennaro Mazza
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 3, pp. 79-81
Closed Access | Times Cited: 39

Melanin-like polydopamine nanoparticles mediating anti-inflammatory and rescuing synaptic loss for inflammatory depression therapy
Tingting Zhu, He Wang, Hanwen Gu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 38

Mitophagy and cGAS–STING crosstalk in neuroinflammation
Xiaogang Zhou, Jing Wang, Lu Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3327-3361
Open Access | Times Cited: 16

Depression and type 2 diabetes: A causal relationship and mechanistic pathway
Wael Y. Khawagi, Hayder M. Al‐kuraishy, Nawar R. Hussein, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3031-3044
Open Access | Times Cited: 16

From degenerative disease to malignant tumors: Insight to the function of ApoE
Ganggang Miao, Danping Zhuo, Xue Han, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114127-114127
Open Access | Times Cited: 32

Possible Effects and Mechanisms of Dietary Natural Products and Nutrients on Depression and Anxiety: A Narrative Review
Si-Xia Wu, Jiahui Li, Dan-Dan Zhou, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2132-2132
Open Access | Times Cited: 31

Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models
Εleni Stamoula, Spyridon Siafis, Ioannis Dardalas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35

White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
Sigrid Breit, Elena Mazza, Sara Poletti, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 22-32
Open Access | Times Cited: 14

Depression and anxiety in multiple sclerosis. Review of a fatal combination
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 8, pp. 847-869
Closed Access | Times Cited: 6

A Systematic Investigation of Complement and Coagulation-Related Protein in Autism Spectrum Disorder Using Multiple Reaction Monitoring Technology
Xueshan Cao, Xiaoxiao Tang, Chengyun Feng, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 11, pp. 1623-1637
Closed Access | Times Cited: 13

Antidepressants and type 2 diabetes: highways to knowns and unknowns
Nahi Sabih Alruwaili, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12

Late chronic local inflammation, synaptic alterations, vascular remodeling and arteriovenous malformations in the brains of male rats exposed to repetitive low-level blast overpressures
Miguel A. Gama Sosa, Rita De Gasperi, Dylan Pryor, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 11

A vascular endothelial cell, neuron, and microglia tri-culture model to study hypertension-related depression
Hongxia Zhao, Lihua Huang, Jian Liu, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access

Neuroinflammation and Natural Antidepressants: Balancing Fire with Flora
Ana Leonor Pardo Campos Godoy, Fernanda Fortes Frota, Larissa Parreira Araújo, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1129-1129
Open Access

Type 2 diabetes mellitus, cerebral small vessel disease and depressive disorders
Victoria Serhiyenko, O.М. Chemerys, V.І. Pankiv, et al.
INTERNATIONAL NEUROLOGICAL JOURNAL (2025) Vol. 21, Iss. 3, pp. 226-237
Open Access

Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis
Giulia Menculini, Elena Chipi, Federico Paolini Paoletti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4440-4440
Open Access | Times Cited: 23

Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
Luana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Neurobiology of Disease (2022) Vol. 172, pp. 105817-105817
Open Access | Times Cited: 15

The mutually reinforcing dynamics between pain and stress: mechanisms, impacts and management strategies
Nour Aboushaar, Natalia Serrano
Frontiers in Pain Research (2024) Vol. 5
Open Access | Times Cited: 3

Multiple Sclerosis and related disorders
R. John Kimoff, Marta Kamińska, Daria A. Trojan
Handbook of clinical neurology (2022), pp. 177-200
Closed Access | Times Cited: 14

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
Maddalena Sparaco, Giuseppina Miele, Luigi Lavorgna, et al.
Neurological Sciences (2022) Vol. 43, Iss. 5, pp. 2935-2942
Open Access | Times Cited: 12

Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
Patrizia LoPresti
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1077-1077
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top